SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-001540
Filing Date
2024-02-09
Accepted
2024-02-09 16:46:52
Documents
63
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 599436
2 CERTIFICATION edsa_ex311.htm EX-31.1 8314
3 CERTIFICATION edsa_ex312.htm EX-31.2 8350
4 CERTIFICATION edsa_ex321.htm EX-32.1 3618
5 CERTIFICATION edsa_ex322.htm EX-32.2 3580
  Complete submission text file 0001654954-24-001540.txt   3415337

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20231231.xsd EX-101.SCH 42383
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20231231_lab.xml EX-101.LAB 219443
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20231231_cal.xml EX-101.CAL 34125
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20231231_pre.xml EX-101.PRE 189528
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20231231_def.xml EX-101.DEF 97046
65 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 499479
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 24615732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)